920 related articles for article (PubMed ID: 8864921)
1. Nuclear morphometry, immunohistochemical staining with Ki-67 antibody and mitotic index in the assessment of proliferative activity and prognosis of primary malignant melanomas of the skin.
Talve LA; Collan YU; Ekfors TO
J Cutan Pathol; 1996 Aug; 23(4):335-43. PubMed ID: 8864921
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of p53 protein, mitotic index and nuclear morphometry in primary malignant melanoma of the skin.
Talve L; Kainu J; Collan Y; Ekfors T
Pathol Res Pract; 1996 Aug; 192(8):825-33. PubMed ID: 8897518
[TBL] [Abstract][Full Text] [Related]
3. Nuclear morphometry of MIB-1 positive and negative tumor cells in primary and metastatic malignant melanoma of the skin.
Karbowniczek M; Chosia M; Domagała W
Pol J Pathol; 1999; 50(4):235-41. PubMed ID: 10721263
[TBL] [Abstract][Full Text] [Related]
4. Ki 67 immunostaining in melanocytic skin tumors. Correlation with histologic parameters.
Soyer HP
J Cutan Pathol; 1991 Aug; 18(4):264-72. PubMed ID: 1719049
[TBL] [Abstract][Full Text] [Related]
5. Comparison of proliferative activity as assessed by proliferating cell nuclear antigen (PCNA) and Ki-67 monoclonal antibodies in melanocytic skin lesions. A quantitative immunohistochemical study.
Rieger E; Hofmann-Wellenhof R; Soyer HP; Kofler R; Cerroni L; Smolle J; Kerl H
J Cutan Pathol; 1993 Jun; 20(3):229-36. PubMed ID: 8103531
[TBL] [Abstract][Full Text] [Related]
6. Primary malignant melanoma of the skin. Relationships of nuclear DNA content, nuclear morphometric variables, Clark level and tumor thickness.
Talve LA; Collan YU; Ekfors TO
Anal Quant Cytol Histol; 1997 Feb; 19(1):62-74. PubMed ID: 9051188
[TBL] [Abstract][Full Text] [Related]
7. MIB-1 proliferative activity is a significant prognostic factor in primary thick cutaneous melanomas.
Ramsay JA; From L; Iscoe NA; Kahn HJ
J Invest Dermatol; 1995 Jul; 105(1):22-6. PubMed ID: 7615970
[TBL] [Abstract][Full Text] [Related]
8. Fractal dimension of chromatin is an independent prognostic factor for survival in melanoma.
Bedin V; Adam RL; de Sá BC; Landman G; Metze K
BMC Cancer; 2010 Jun; 10():260. PubMed ID: 20525386
[TBL] [Abstract][Full Text] [Related]
9. MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma.
Böni R; Doguoglu A; Burg G; Müller B; Dummer R
J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):416-8. PubMed ID: 8784279
[TBL] [Abstract][Full Text] [Related]
10. Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma.
Ladstein RG; Bachmann IM; Straume O; Akslen LA
BMC Cancer; 2010 Apr; 10():140. PubMed ID: 20398247
[TBL] [Abstract][Full Text] [Related]
11. Correlation of Ki-67 expression in cutaneous primary melanoma with prognosis in a prospective study: different correlation according to thickness.
Moretti S; Spallanzani A; Chiarugi A; Fabiani M; Pinzi C
J Am Acad Dermatol; 2001 Feb; 44(2):188-92. PubMed ID: 11174375
[TBL] [Abstract][Full Text] [Related]
12. High proliferative activity may predict early metastasis of thin melanomas.
Frahm SO; Schubert C; Parwaresch R; Rudolph P
Hum Pathol; 2001 Dec; 32(12):1376-81. PubMed ID: 11774172
[TBL] [Abstract][Full Text] [Related]
13. Correlation of nuclear morphometry of primary melanoma of the skin with clinicopathological parameters and expression of tumor suppressor proteins (p53 and p16(INK4a)) and bcl-2 oncoprotein.
Mijovic Z; Kostov M; Mihailovic D; Zivkovic N; Stojanovic M; Zdravkovic M
J BUON; 2013; 18(2):471-6. PubMed ID: 23818364
[TBL] [Abstract][Full Text] [Related]
14. PRAME expression in cutaneous melanoma does not correlate with disease-specific survival.
Parra O; Ma W; Li Z; Coffing BN; Linos K; LeBlanc RE; Momtahen S; Sriharan A; Cloutier JM; Wells WA; Yan S
J Cutan Pathol; 2023 Oct; 50(10):903-912. PubMed ID: 37430414
[TBL] [Abstract][Full Text] [Related]
15. [Correlation between tumor cell proliferation and prognosis of primary cutaneous malignant melanoma in 127 patients].
Wang Y; Xue WC; Si L; Cui CL; Lu AP; Cao DF; Guo J; Li ZW
Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):178-81. PubMed ID: 23769437
[TBL] [Abstract][Full Text] [Related]
16. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
Wat H; Senthilselvan A; Salopek TG
J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of Ki-67 expression in localized cutaneous malignant melanoma.
Henrique R; Azevedo R; Bento MJ; Domingues JC; Silva C; Jerónimo C
J Am Acad Dermatol; 2000 Dec; 43(6):991-1000. PubMed ID: 11100014
[TBL] [Abstract][Full Text] [Related]
18. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.
Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V
J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132
[TBL] [Abstract][Full Text] [Related]
19. p53-protein and Ki-67-antigen expression are both reliable biomarkers of prognosis in thick stage I nodular melanomas of the skin.
Vogt T; Zipperer KH; Vogt A; Hölzel D; Landthaler M; Stolz W
Histopathology; 1997 Jan; 30(1):57-63. PubMed ID: 9023558
[TBL] [Abstract][Full Text] [Related]
20. Prognostic evaluation of cutaneous malignant melanoma: a clinicopathologic and immunohistochemical study.
Niezabitowski A; Czajecki K; Ryś J; Kruczak A; Gruchała A; Wasilewska A; Lackowska B; Sokołowski A; Szklarski W
J Surg Oncol; 1999 Mar; 70(3):150-60. PubMed ID: 10102344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
